0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Peptide Drug Synthesis Reagents Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-22N19014
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Peptide Drug Synthesis Reagents Market Research Report 2025
BUY CHAPTERS

Global Peptide Drug Synthesis Reagents Market Research Report 2025

Code: QYRE-Auto-22N19014
Report
March 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Peptide Drug Synthesis Reagents Market Size

The global market for Peptide Drug Synthesis Reagents was valued at US$ 1051 million in the year 2024 and is projected to reach a revised size of US$ 1615 million by 2031, growing at a CAGR of 4.9% during the forecast period.

Peptide Drug Synthesis Reagents Market

Peptide Drug Synthesis Reagents Market

Peptide synthesis reagents play a crucial role in the synthesis of peptide drugs. Peptide drugs are composed of amino acid units linked by amide bonds (-CO-NH-), which are formed through a dehydration condensation reaction between the carboxyl (-COOH) group of one amino acid and the amino (-NH2) group of another. These specialized chemical reagents are essential for optimizing amide bond formation, significantly enhancing reaction efficiency, improving product purity, and increasing overall yield. Peptide synthesis reagents are indispensable in the development of peptide-based drugs and small-molecule pharmaceuticals, making them a vital component in modern drug research and production.
North American market for Peptide Drug Synthesis Reagents is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Peptide Drug Synthesis Reagents is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Peptide Drug Synthesis Reagents include Merck, Iris Biotech, Curia Global, SVAK Life Sciences, Watanabe Chemical Industries, Suzhou Highfine Biotech, Shandong Jincheng Pharmaceutical, Zhejiang Bulk Chemical, Zibo Tiantangshan Chemical, Huanggang Luban Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Peptide Drug Synthesis Reagents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Drug Synthesis Reagents.
The Peptide Drug Synthesis Reagents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide Drug Synthesis Reagents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide Drug Synthesis Reagents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Peptide Drug Synthesis Reagents Market Report

Report Metric Details
Report Name Peptide Drug Synthesis Reagents Market
Accounted market size in year US$ 1051 million
Forecasted market size in 2031 US$ 1615 million
CAGR 4.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Condensation Reagents
  • Protective Reagents
  • Chiral Racemization Inhibition Reagents
Segment by Application
  • Orthopedics
  • Cardiovascular
  • Metabolic Diseases
  • Tumors
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Iris Biotech, Curia Global, SVAK Life Sciences, Watanabe Chemical Industries, Suzhou Highfine Biotech, Shandong Jincheng Pharmaceutical, Zhejiang Bulk Chemical, Zibo Tiantangshan Chemical, Huanggang Luban Pharmaceutical, GL Biochem, GenChem & GenPharm, Ningxia Jinxiang Pharmaceutical Chemical, Changzhou Hubin Medicine, Zhejiang Wild Wind Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Peptide Drug Synthesis Reagents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Peptide Drug Synthesis Reagents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Peptide Drug Synthesis Reagents Market growing?

Ans: The Peptide Drug Synthesis Reagents Market witnessing a CAGR of 4.9% during the forecast period 2025-2031.

What is the Peptide Drug Synthesis Reagents Market size in 2031?

Ans: The Peptide Drug Synthesis Reagents Market size in 2031 will be US$ 1615 million.

Who are the main players in the Peptide Drug Synthesis Reagents Market report?

Ans: The main players in the Peptide Drug Synthesis Reagents Market are Merck, Iris Biotech, Curia Global, SVAK Life Sciences, Watanabe Chemical Industries, Suzhou Highfine Biotech, Shandong Jincheng Pharmaceutical, Zhejiang Bulk Chemical, Zibo Tiantangshan Chemical, Huanggang Luban Pharmaceutical, GL Biochem, GenChem & GenPharm, Ningxia Jinxiang Pharmaceutical Chemical, Changzhou Hubin Medicine, Zhejiang Wild Wind Pharmaceutical

What are the Application segmentation covered in the Peptide Drug Synthesis Reagents Market report?

Ans: The Applications covered in the Peptide Drug Synthesis Reagents Market report are Orthopedics, Cardiovascular, Metabolic Diseases, Tumors, Others

What are the Type segmentation covered in the Peptide Drug Synthesis Reagents Market report?

Ans: The Types covered in the Peptide Drug Synthesis Reagents Market report are Condensation Reagents, Protective Reagents, Chiral Racemization Inhibition Reagents

1 Peptide Drug Synthesis Reagents Market Overview
1.1 Product Definition
1.2 Peptide Drug Synthesis Reagents by Type
1.2.1 Global Peptide Drug Synthesis Reagents Market Value Comparison by Type (2024 VS 2031)
1.2.2 Condensation Reagents
1.2.3 Protective Reagents
1.2.4 Chiral Racemization Inhibition Reagents
1.3 Peptide Drug Synthesis Reagents by Application
1.3.1 Global Peptide Drug Synthesis Reagents Market Value by Application (2024 VS 2031)
1.3.2 Orthopedics
1.3.3 Cardiovascular
1.3.4 Metabolic Diseases
1.3.5 Tumors
1.3.6 Others
1.4 Global Peptide Drug Synthesis Reagents Market Size Estimates and Forecasts
1.4.1 Global Peptide Drug Synthesis Reagents Revenue 2020-2031
1.4.2 Global Peptide Drug Synthesis Reagents Sales 2020-2031
1.4.3 Global Peptide Drug Synthesis Reagents Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Peptide Drug Synthesis Reagents Market Competition by Manufacturers
2.1 Global Peptide Drug Synthesis Reagents Sales Market Share by Manufacturers (2020-2025)
2.2 Global Peptide Drug Synthesis Reagents Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Peptide Drug Synthesis Reagents Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Peptide Drug Synthesis Reagents, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Peptide Drug Synthesis Reagents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Peptide Drug Synthesis Reagents, Product Type & Application
2.7 Global Key Manufacturers of Peptide Drug Synthesis Reagents, Date of Enter into This Industry
2.8 Global Peptide Drug Synthesis Reagents Market Competitive Situation and Trends
2.8.1 Global Peptide Drug Synthesis Reagents Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Peptide Drug Synthesis Reagents Players Market Share by Revenue
2.8.3 Global Peptide Drug Synthesis Reagents Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Peptide Drug Synthesis Reagents Market Scenario by Region
3.1 Global Peptide Drug Synthesis Reagents Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Peptide Drug Synthesis Reagents Sales by Region: 2020-2031
3.2.1 Global Peptide Drug Synthesis Reagents Sales by Region: 2020-2025
3.2.2 Global Peptide Drug Synthesis Reagents Sales by Region: 2026-2031
3.3 Global Peptide Drug Synthesis Reagents Revenue by Region: 2020-2031
3.3.1 Global Peptide Drug Synthesis Reagents Revenue by Region: 2020-2025
3.3.2 Global Peptide Drug Synthesis Reagents Revenue by Region: 2026-2031
3.4 North America Peptide Drug Synthesis Reagents Market Facts & Figures by Country
3.4.1 North America Peptide Drug Synthesis Reagents Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Peptide Drug Synthesis Reagents Sales by Country (2020-2031)
3.4.3 North America Peptide Drug Synthesis Reagents Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Peptide Drug Synthesis Reagents Market Facts & Figures by Country
3.5.1 Europe Peptide Drug Synthesis Reagents Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Peptide Drug Synthesis Reagents Sales by Country (2020-2031)
3.5.3 Europe Peptide Drug Synthesis Reagents Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Peptide Drug Synthesis Reagents Market Facts & Figures by Region
3.6.1 Asia Pacific Peptide Drug Synthesis Reagents Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Peptide Drug Synthesis Reagents Sales by Region (2020-2031)
3.6.3 Asia Pacific Peptide Drug Synthesis Reagents Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Peptide Drug Synthesis Reagents Market Facts & Figures by Country
3.7.1 Latin America Peptide Drug Synthesis Reagents Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Peptide Drug Synthesis Reagents Sales by Country (2020-2031)
3.7.3 Latin America Peptide Drug Synthesis Reagents Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Peptide Drug Synthesis Reagents Market Facts & Figures by Country
3.8.1 Middle East and Africa Peptide Drug Synthesis Reagents Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Peptide Drug Synthesis Reagents Sales by Country (2020-2031)
3.8.3 Middle East and Africa Peptide Drug Synthesis Reagents Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Peptide Drug Synthesis Reagents Sales by Type (2020-2031)
4.1.1 Global Peptide Drug Synthesis Reagents Sales by Type (2020-2025)
4.1.2 Global Peptide Drug Synthesis Reagents Sales by Type (2026-2031)
4.1.3 Global Peptide Drug Synthesis Reagents Sales Market Share by Type (2020-2031)
4.2 Global Peptide Drug Synthesis Reagents Revenue by Type (2020-2031)
4.2.1 Global Peptide Drug Synthesis Reagents Revenue by Type (2020-2025)
4.2.2 Global Peptide Drug Synthesis Reagents Revenue by Type (2026-2031)
4.2.3 Global Peptide Drug Synthesis Reagents Revenue Market Share by Type (2020-2031)
4.3 Global Peptide Drug Synthesis Reagents Price by Type (2020-2031)
5 Segment by Application
5.1 Global Peptide Drug Synthesis Reagents Sales by Application (2020-2031)
5.1.1 Global Peptide Drug Synthesis Reagents Sales by Application (2020-2025)
5.1.2 Global Peptide Drug Synthesis Reagents Sales by Application (2026-2031)
5.1.3 Global Peptide Drug Synthesis Reagents Sales Market Share by Application (2020-2031)
5.2 Global Peptide Drug Synthesis Reagents Revenue by Application (2020-2031)
5.2.1 Global Peptide Drug Synthesis Reagents Revenue by Application (2020-2025)
5.2.2 Global Peptide Drug Synthesis Reagents Revenue by Application (2026-2031)
5.2.3 Global Peptide Drug Synthesis Reagents Revenue Market Share by Application (2020-2031)
5.3 Global Peptide Drug Synthesis Reagents Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Peptide Drug Synthesis Reagents Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Peptide Drug Synthesis Reagents Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Iris Biotech
6.2.1 Iris Biotech Company Information
6.2.2 Iris Biotech Description and Business Overview
6.2.3 Iris Biotech Peptide Drug Synthesis Reagents Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Iris Biotech Peptide Drug Synthesis Reagents Product Portfolio
6.2.5 Iris Biotech Recent Developments/Updates
6.3 Curia Global
6.3.1 Curia Global Company Information
6.3.2 Curia Global Description and Business Overview
6.3.3 Curia Global Peptide Drug Synthesis Reagents Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Curia Global Peptide Drug Synthesis Reagents Product Portfolio
6.3.5 Curia Global Recent Developments/Updates
6.4 SVAK Life Sciences
6.4.1 SVAK Life Sciences Company Information
6.4.2 SVAK Life Sciences Description and Business Overview
6.4.3 SVAK Life Sciences Peptide Drug Synthesis Reagents Sales, Revenue and Gross Margin (2020-2025)
6.4.4 SVAK Life Sciences Peptide Drug Synthesis Reagents Product Portfolio
6.4.5 SVAK Life Sciences Recent Developments/Updates
6.5 Watanabe Chemical Industries
6.5.1 Watanabe Chemical Industries Company Information
6.5.2 Watanabe Chemical Industries Description and Business Overview
6.5.3 Watanabe Chemical Industries Peptide Drug Synthesis Reagents Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Watanabe Chemical Industries Peptide Drug Synthesis Reagents Product Portfolio
6.5.5 Watanabe Chemical Industries Recent Developments/Updates
6.6 Suzhou Highfine Biotech
6.6.1 Suzhou Highfine Biotech Company Information
6.6.2 Suzhou Highfine Biotech Description and Business Overview
6.6.3 Suzhou Highfine Biotech Peptide Drug Synthesis Reagents Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Suzhou Highfine Biotech Peptide Drug Synthesis Reagents Product Portfolio
6.6.5 Suzhou Highfine Biotech Recent Developments/Updates
6.7 Shandong Jincheng Pharmaceutical
6.7.1 Shandong Jincheng Pharmaceutical Company Information
6.7.2 Shandong Jincheng Pharmaceutical Description and Business Overview
6.7.3 Shandong Jincheng Pharmaceutical Peptide Drug Synthesis Reagents Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Shandong Jincheng Pharmaceutical Peptide Drug Synthesis Reagents Product Portfolio
6.7.5 Shandong Jincheng Pharmaceutical Recent Developments/Updates
6.8 Zhejiang Bulk Chemical
6.8.1 Zhejiang Bulk Chemical Company Information
6.8.2 Zhejiang Bulk Chemical Description and Business Overview
6.8.3 Zhejiang Bulk Chemical Peptide Drug Synthesis Reagents Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Zhejiang Bulk Chemical Peptide Drug Synthesis Reagents Product Portfolio
6.8.5 Zhejiang Bulk Chemical Recent Developments/Updates
6.9 Zibo Tiantangshan Chemical
6.9.1 Zibo Tiantangshan Chemical Company Information
6.9.2 Zibo Tiantangshan Chemical Description and Business Overview
6.9.3 Zibo Tiantangshan Chemical Peptide Drug Synthesis Reagents Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Zibo Tiantangshan Chemical Peptide Drug Synthesis Reagents Product Portfolio
6.9.5 Zibo Tiantangshan Chemical Recent Developments/Updates
6.10 Huanggang Luban Pharmaceutical
6.10.1 Huanggang Luban Pharmaceutical Company Information
6.10.2 Huanggang Luban Pharmaceutical Description and Business Overview
6.10.3 Huanggang Luban Pharmaceutical Peptide Drug Synthesis Reagents Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Huanggang Luban Pharmaceutical Peptide Drug Synthesis Reagents Product Portfolio
6.10.5 Huanggang Luban Pharmaceutical Recent Developments/Updates
6.11 GL Biochem
6.11.1 GL Biochem Company Information
6.11.2 GL Biochem Description and Business Overview
6.11.3 GL Biochem Peptide Drug Synthesis Reagents Sales, Revenue and Gross Margin (2020-2025)
6.11.4 GL Biochem Peptide Drug Synthesis Reagents Product Portfolio
6.11.5 GL Biochem Recent Developments/Updates
6.12 GenChem & GenPharm
6.12.1 GenChem & GenPharm Company Information
6.12.2 GenChem & GenPharm Description and Business Overview
6.12.3 GenChem & GenPharm Peptide Drug Synthesis Reagents Sales, Revenue and Gross Margin (2020-2025)
6.12.4 GenChem & GenPharm Peptide Drug Synthesis Reagents Product Portfolio
6.12.5 GenChem & GenPharm Recent Developments/Updates
6.13 Ningxia Jinxiang Pharmaceutical Chemical
6.13.1 Ningxia Jinxiang Pharmaceutical Chemical Company Information
6.13.2 Ningxia Jinxiang Pharmaceutical Chemical Description and Business Overview
6.13.3 Ningxia Jinxiang Pharmaceutical Chemical Peptide Drug Synthesis Reagents Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Ningxia Jinxiang Pharmaceutical Chemical Peptide Drug Synthesis Reagents Product Portfolio
6.13.5 Ningxia Jinxiang Pharmaceutical Chemical Recent Developments/Updates
6.14 Changzhou Hubin Medicine
6.14.1 Changzhou Hubin Medicine Company Information
6.14.2 Changzhou Hubin Medicine Description and Business Overview
6.14.3 Changzhou Hubin Medicine Peptide Drug Synthesis Reagents Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Changzhou Hubin Medicine Peptide Drug Synthesis Reagents Product Portfolio
6.14.5 Changzhou Hubin Medicine Recent Developments/Updates
6.15 Zhejiang Wild Wind Pharmaceutical
6.15.1 Zhejiang Wild Wind Pharmaceutical Company Information
6.15.2 Zhejiang Wild Wind Pharmaceutical Description and Business Overview
6.15.3 Zhejiang Wild Wind Pharmaceutical Peptide Drug Synthesis Reagents Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Zhejiang Wild Wind Pharmaceutical Peptide Drug Synthesis Reagents Product Portfolio
6.15.5 Zhejiang Wild Wind Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Peptide Drug Synthesis Reagents Industry Chain Analysis
7.2 Peptide Drug Synthesis Reagents Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Peptide Drug Synthesis Reagents Production Mode & Process Analysis
7.4 Peptide Drug Synthesis Reagents Sales and Marketing
7.4.1 Peptide Drug Synthesis Reagents Sales Channels
7.4.2 Peptide Drug Synthesis Reagents Distributors
7.5 Peptide Drug Synthesis Reagents Customer Analysis
8 Peptide Drug Synthesis Reagents Market Dynamics
8.1 Peptide Drug Synthesis Reagents Industry Trends
8.2 Peptide Drug Synthesis Reagents Market Drivers
8.3 Peptide Drug Synthesis Reagents Market Challenges
8.4 Peptide Drug Synthesis Reagents Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Peptide Drug Synthesis Reagents Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Peptide Drug Synthesis Reagents Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Peptide Drug Synthesis Reagents Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Peptide Drug Synthesis Reagents Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Peptide Drug Synthesis Reagents Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Peptide Drug Synthesis Reagents Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Peptide Drug Synthesis Reagents Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Peptide Drug Synthesis Reagents Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Peptide Drug Synthesis Reagents, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Peptide Drug Synthesis Reagents, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Peptide Drug Synthesis Reagents, Product Type & Application
 Table 12. Global Key Manufacturers of Peptide Drug Synthesis Reagents, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Peptide Drug Synthesis Reagents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Drug Synthesis Reagents as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Peptide Drug Synthesis Reagents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Peptide Drug Synthesis Reagents Sales by Region (2020-2025) & (K Units)
 Table 18. Global Peptide Drug Synthesis Reagents Sales Market Share by Region (2020-2025)
 Table 19. Global Peptide Drug Synthesis Reagents Sales by Region (2026-2031) & (K Units)
 Table 20. Global Peptide Drug Synthesis Reagents Sales Market Share by Region (2026-2031)
 Table 21. Global Peptide Drug Synthesis Reagents Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Peptide Drug Synthesis Reagents Revenue Market Share by Region (2020-2025)
 Table 23. Global Peptide Drug Synthesis Reagents Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Peptide Drug Synthesis Reagents Revenue Market Share by Region (2026-2031)
 Table 25. North America Peptide Drug Synthesis Reagents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Peptide Drug Synthesis Reagents Sales by Country (2020-2025) & (K Units)
 Table 27. North America Peptide Drug Synthesis Reagents Sales by Country (2026-2031) & (K Units)
 Table 28. North America Peptide Drug Synthesis Reagents Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Peptide Drug Synthesis Reagents Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Peptide Drug Synthesis Reagents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Peptide Drug Synthesis Reagents Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Peptide Drug Synthesis Reagents Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Peptide Drug Synthesis Reagents Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Peptide Drug Synthesis Reagents Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Peptide Drug Synthesis Reagents Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Peptide Drug Synthesis Reagents Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Peptide Drug Synthesis Reagents Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Peptide Drug Synthesis Reagents Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Peptide Drug Synthesis Reagents Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Peptide Drug Synthesis Reagents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Peptide Drug Synthesis Reagents Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Peptide Drug Synthesis Reagents Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Peptide Drug Synthesis Reagents Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Peptide Drug Synthesis Reagents Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Peptide Drug Synthesis Reagents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Peptide Drug Synthesis Reagents Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Peptide Drug Synthesis Reagents Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Peptide Drug Synthesis Reagents Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Peptide Drug Synthesis Reagents Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Peptide Drug Synthesis Reagents Sales (K Units) by Type (2020-2025)
 Table 51. Global Peptide Drug Synthesis Reagents Sales (K Units) by Type (2026-2031)
 Table 52. Global Peptide Drug Synthesis Reagents Sales Market Share by Type (2020-2025)
 Table 53. Global Peptide Drug Synthesis Reagents Sales Market Share by Type (2026-2031)
 Table 54. Global Peptide Drug Synthesis Reagents Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Peptide Drug Synthesis Reagents Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Peptide Drug Synthesis Reagents Revenue Market Share by Type (2020-2025)
 Table 57. Global Peptide Drug Synthesis Reagents Revenue Market Share by Type (2026-2031)
 Table 58. Global Peptide Drug Synthesis Reagents Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Peptide Drug Synthesis Reagents Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Peptide Drug Synthesis Reagents Sales (K Units) by Application (2020-2025)
 Table 61. Global Peptide Drug Synthesis Reagents Sales (K Units) by Application (2026-2031)
 Table 62. Global Peptide Drug Synthesis Reagents Sales Market Share by Application (2020-2025)
 Table 63. Global Peptide Drug Synthesis Reagents Sales Market Share by Application (2026-2031)
 Table 64. Global Peptide Drug Synthesis Reagents Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Peptide Drug Synthesis Reagents Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Peptide Drug Synthesis Reagents Revenue Market Share by Application (2020-2025)
 Table 67. Global Peptide Drug Synthesis Reagents Revenue Market Share by Application (2026-2031)
 Table 68. Global Peptide Drug Synthesis Reagents Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Peptide Drug Synthesis Reagents Price (US$/Unit) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Peptide Drug Synthesis Reagents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Merck Peptide Drug Synthesis Reagents Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Iris Biotech Company Information
 Table 76. Iris Biotech Description and Business Overview
 Table 77. Iris Biotech Peptide Drug Synthesis Reagents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Iris Biotech Peptide Drug Synthesis Reagents Product
 Table 79. Iris Biotech Recent Developments/Updates
 Table 80. Curia Global Company Information
 Table 81. Curia Global Description and Business Overview
 Table 82. Curia Global Peptide Drug Synthesis Reagents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Curia Global Peptide Drug Synthesis Reagents Product
 Table 84. Curia Global Recent Developments/Updates
 Table 85. SVAK Life Sciences Company Information
 Table 86. SVAK Life Sciences Description and Business Overview
 Table 87. SVAK Life Sciences Peptide Drug Synthesis Reagents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. SVAK Life Sciences Peptide Drug Synthesis Reagents Product
 Table 89. SVAK Life Sciences Recent Developments/Updates
 Table 90. Watanabe Chemical Industries Company Information
 Table 91. Watanabe Chemical Industries Description and Business Overview
 Table 92. Watanabe Chemical Industries Peptide Drug Synthesis Reagents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Watanabe Chemical Industries Peptide Drug Synthesis Reagents Product
 Table 94. Watanabe Chemical Industries Recent Developments/Updates
 Table 95. Suzhou Highfine Biotech Company Information
 Table 96. Suzhou Highfine Biotech Description and Business Overview
 Table 97. Suzhou Highfine Biotech Peptide Drug Synthesis Reagents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Suzhou Highfine Biotech Peptide Drug Synthesis Reagents Product
 Table 99. Suzhou Highfine Biotech Recent Developments/Updates
 Table 100. Shandong Jincheng Pharmaceutical Company Information
 Table 101. Shandong Jincheng Pharmaceutical Description and Business Overview
 Table 102. Shandong Jincheng Pharmaceutical Peptide Drug Synthesis Reagents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Shandong Jincheng Pharmaceutical Peptide Drug Synthesis Reagents Product
 Table 104. Shandong Jincheng Pharmaceutical Recent Developments/Updates
 Table 105. Zhejiang Bulk Chemical Company Information
 Table 106. Zhejiang Bulk Chemical Description and Business Overview
 Table 107. Zhejiang Bulk Chemical Peptide Drug Synthesis Reagents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Zhejiang Bulk Chemical Peptide Drug Synthesis Reagents Product
 Table 109. Zhejiang Bulk Chemical Recent Developments/Updates
 Table 110. Zibo Tiantangshan Chemical Company Information
 Table 111. Zibo Tiantangshan Chemical Description and Business Overview
 Table 112. Zibo Tiantangshan Chemical Peptide Drug Synthesis Reagents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Zibo Tiantangshan Chemical Peptide Drug Synthesis Reagents Product
 Table 114. Zibo Tiantangshan Chemical Recent Developments/Updates
 Table 115. Huanggang Luban Pharmaceutical Company Information
 Table 116. Huanggang Luban Pharmaceutical Description and Business Overview
 Table 117. Huanggang Luban Pharmaceutical Peptide Drug Synthesis Reagents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Huanggang Luban Pharmaceutical Peptide Drug Synthesis Reagents Product
 Table 119. Huanggang Luban Pharmaceutical Recent Developments/Updates
 Table 120. GL Biochem Company Information
 Table 121. GL Biochem Description and Business Overview
 Table 122. GL Biochem Peptide Drug Synthesis Reagents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. GL Biochem Peptide Drug Synthesis Reagents Product
 Table 124. GL Biochem Recent Developments/Updates
 Table 125. GenChem & GenPharm Company Information
 Table 126. GenChem & GenPharm Description and Business Overview
 Table 127. GenChem & GenPharm Peptide Drug Synthesis Reagents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. GenChem & GenPharm Peptide Drug Synthesis Reagents Product
 Table 129. GenChem & GenPharm Recent Developments/Updates
 Table 130. Ningxia Jinxiang Pharmaceutical Chemical Company Information
 Table 131. Ningxia Jinxiang Pharmaceutical Chemical Description and Business Overview
 Table 132. Ningxia Jinxiang Pharmaceutical Chemical Peptide Drug Synthesis Reagents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Ningxia Jinxiang Pharmaceutical Chemical Peptide Drug Synthesis Reagents Product
 Table 134. Ningxia Jinxiang Pharmaceutical Chemical Recent Developments/Updates
 Table 135. Changzhou Hubin Medicine Company Information
 Table 136. Changzhou Hubin Medicine Description and Business Overview
 Table 137. Changzhou Hubin Medicine Peptide Drug Synthesis Reagents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Changzhou Hubin Medicine Peptide Drug Synthesis Reagents Product
 Table 139. Changzhou Hubin Medicine Recent Developments/Updates
 Table 140. Zhejiang Wild Wind Pharmaceutical Company Information
 Table 141. Zhejiang Wild Wind Pharmaceutical Description and Business Overview
 Table 142. Zhejiang Wild Wind Pharmaceutical Peptide Drug Synthesis Reagents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Zhejiang Wild Wind Pharmaceutical Peptide Drug Synthesis Reagents Product
 Table 144. Zhejiang Wild Wind Pharmaceutical Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Peptide Drug Synthesis Reagents Distributors List
 Table 148. Peptide Drug Synthesis Reagents Customers List
 Table 149. Peptide Drug Synthesis Reagents Market Trends
 Table 150. Peptide Drug Synthesis Reagents Market Drivers
 Table 151. Peptide Drug Synthesis Reagents Market Challenges
 Table 152. Peptide Drug Synthesis Reagents Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Peptide Drug Synthesis Reagents
 Figure 2. Global Peptide Drug Synthesis Reagents Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Peptide Drug Synthesis Reagents Market Share by Type: 2024 & 2031
 Figure 4. Condensation Reagents Product Picture
 Figure 5. Protective Reagents Product Picture
 Figure 6. Chiral Racemization Inhibition Reagents Product Picture
 Figure 7. Global Peptide Drug Synthesis Reagents Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Peptide Drug Synthesis Reagents Market Share by Application: 2024 & 2031
 Figure 9. Orthopedics
 Figure 10. Cardiovascular
 Figure 11. Metabolic Diseases
 Figure 12. Tumors
 Figure 13. Others
 Figure 14. Global Peptide Drug Synthesis Reagents Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Peptide Drug Synthesis Reagents Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Peptide Drug Synthesis Reagents Sales (2020-2031) & (K Units)
 Figure 17. Global Peptide Drug Synthesis Reagents Average Price (US$/Unit) & (2020-2031)
 Figure 18. Peptide Drug Synthesis Reagents Report Years Considered
 Figure 19. Peptide Drug Synthesis Reagents Sales Share by Manufacturers in 2024
 Figure 20. Global Peptide Drug Synthesis Reagents Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Peptide Drug Synthesis Reagents Players: Market Share by Revenue in Peptide Drug Synthesis Reagents in 2024
 Figure 22. Peptide Drug Synthesis Reagents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Peptide Drug Synthesis Reagents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Peptide Drug Synthesis Reagents Sales Market Share by Country (2020-2031)
 Figure 25. North America Peptide Drug Synthesis Reagents Revenue Market Share by Country (2020-2031)
 Figure 26. United States Peptide Drug Synthesis Reagents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Peptide Drug Synthesis Reagents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Peptide Drug Synthesis Reagents Sales Market Share by Country (2020-2031)
 Figure 29. Europe Peptide Drug Synthesis Reagents Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Peptide Drug Synthesis Reagents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Peptide Drug Synthesis Reagents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Peptide Drug Synthesis Reagents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Peptide Drug Synthesis Reagents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Peptide Drug Synthesis Reagents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Peptide Drug Synthesis Reagents Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Peptide Drug Synthesis Reagents Revenue Market Share by Region (2020-2031)
 Figure 37. China Peptide Drug Synthesis Reagents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Peptide Drug Synthesis Reagents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Peptide Drug Synthesis Reagents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Peptide Drug Synthesis Reagents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Peptide Drug Synthesis Reagents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Peptide Drug Synthesis Reagents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia Peptide Drug Synthesis Reagents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Peptide Drug Synthesis Reagents Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Peptide Drug Synthesis Reagents Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Peptide Drug Synthesis Reagents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Peptide Drug Synthesis Reagents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Peptide Drug Synthesis Reagents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Colombia Peptide Drug Synthesis Reagents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Peptide Drug Synthesis Reagents Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Peptide Drug Synthesis Reagents Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Peptide Drug Synthesis Reagents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Peptide Drug Synthesis Reagents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Peptide Drug Synthesis Reagents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Peptide Drug Synthesis Reagents by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Peptide Drug Synthesis Reagents by Type (2020-2031)
 Figure 57. Global Peptide Drug Synthesis Reagents Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Peptide Drug Synthesis Reagents by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Peptide Drug Synthesis Reagents by Application (2020-2031)
 Figure 60. Global Peptide Drug Synthesis Reagents Price (US$/Unit) by Application (2020-2031)
 Figure 61. Peptide Drug Synthesis Reagents Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String